Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study
Main Authors: | Laura Paulowski, Roxana Filip, Mateja Jankovic Makek, Lorenzo Guglielmetti, Delia Goletti, Jakko van Ingen, Katharina Kranzer, Florian P. Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020973/?tool=EBI |
Similar Items
-
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group
by: Solomon Tibebu Melkie, et al.
Published: (2022-03-01) -
Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries?
by: Frédéric Méchaï, et al.
Published: (2020-09-01) -
Treatment of Diabetes Mellitus by Acupuncture: Dynamics of Blood Glucose Level and Its Mathematical Modelling
by: Marija Šimat, et al.
Published: (2023-09-01) -
‘Those who cannot remember the past are condemned to repeat it’: Drug-susceptibility testing for bedaquiline and delamanid
by: Claudio U. Köser, et al.
Published: (2019-03-01) -
Successful pleurodesis of refractory pleural effusion caused by he-art failure due to restrictive cardiomyopathy caused by amyloidosis
by: Zrinka Madunić, et al.
Published: (2023-01-01)